The frequency at which of CD8+ T cells expressed several of these immune targets, such as PD-1, LAG-3, CTLA-4, and CD39, was higher in the glioma microenvironment than in the PBMCs from patients with GBM and healthy donors (Figure 2, A and B). The gene discussed is LAG3; the disease is central nervous system cancer.